- Novartis has announced 5.65bn euros ($7.4bn; Â£3.9bn) of purchases to make its Sandoz unit the world's biggest generic drug producer.
- Novartis said that it would be able to make cost savings of about $200m a year following the acquisitions.
- The deal will see Novartis' Sandoz business overtake Israel's Teva Pharmaceuticals as the world's biggest maker of generics.
